Cardiogenesis Settles Disagreement With Ex-CEO

Law360, New York (October 19, 2006, 12:00 AM EDT) -- Medical device maker Cardiogenesis Corp. said in a financial filing Wednesday that it had reached an agreement with its former chief executive officer over issues relating to his termination.

The company’s filing with the U.S. Securities and Exchange Commission said that Cardiogenesis would pay Michael Quinn $550,000 in 72 equal bi-monthly payments.

Up to $75,000 of that amount will be paid to his attorney as fees. The agreement was reached Oct. 12.

Quinn will also be allowed to keep $689,008 in previously issued stock options with...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.